Medios AG
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. The company operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic preparations, antibody therapies, a… Read more
Medios AG (MEDOF) - Total Assets
Latest total assets as of September 2025: $939.33 Million USD
Based on the latest financial reports, Medios AG (MEDOF) holds total assets worth $939.33 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Medios AG - Total Assets Trend (2009–2024)
This chart illustrates how Medios AG’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Medios AG - Asset Composition Analysis
Current Asset Composition (December 2024)
Medios AG's total assets of $939.33 Million consist of 37.0% current assets and 63.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 11.3% |
| Accounts Receivable | $129.02 Million | 13.8% |
| Inventory | $90.42 Million | 9.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $148.28 Million | 15.9% |
| Goodwill | $361.61 Million | 38.7% |
Asset Composition Trend (2009–2024)
This chart illustrates how Medios AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medios AG's current assets represent 37.0% of total assets in 2024, a decrease from 74.0% in 2009.
- Cash Position: Cash and equivalents constituted 11.3% of total assets in 2024, up from 1.3% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 53.0% of total assets, an increase from 0.0% in 2009.
- Asset Diversification: The largest asset category is goodwill at 38.7% of total assets.
Medios AG Competitors by Total Assets
Key competitors of Medios AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
|
China | CN¥67.71 Billion |
|
Shenzhen Glory Medical Co Ltd
SHE:002551
|
China | CN¥3.56 Billion |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
China | CN¥15.33 Billion |
|
Hanmi Science
KO:008930
|
Korea | ₩1.45 Trillion |
|
BCM Alliance Bhd
KLSE:0187
|
Malaysia | RM147.86 Million |
|
Qingdao Baheal Medical INC.
SHE:301015
|
China | CN¥7.59 Billion |
|
Excelsior Medical Co Ltd
TW:4104
|
Taiwan | NT$18.80 Billion |
|
CHC Healthcare Group
TW:4164
|
Taiwan | NT$14.83 Billion |
Medios AG - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Medios AG generates 2.02x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Medios AG generates $ 1.34 in net profit.
Medios AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.74 | 0.99 | 4.45 |
| Quick Ratio | 1.31 | 0.76 | 3.33 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $159.28 Million | $ -3.78 Million | $ 105.68 Million |
Medios AG - Advanced Valuation Insights
This section examines the relationship between Medios AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.25 |
| Latest Market Cap to Assets Ratio | 0.50 |
| Asset Growth Rate (YoY) | 57.1% |
| Total Assets | $934.36 Million |
| Market Capitalization | $466.82 Million USD |
Valuation Analysis
Below Book Valuation: The market values Medios AG's assets below their book value (0.50 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Medios AG's assets grew by 57.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Medios AG (2009–2024)
The table below shows the annual total assets of Medios AG from 2009 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $934.36 Million | +57.10% |
| 2023-12-31 | $594.75 Million | +3.26% |
| 2022-12-31 | $575.96 Million | +9.89% |
| 2021-12-31 | $524.14 Million | +169.43% |
| 2020-12-31 | $194.54 Million | +66.89% |
| 2019-12-31 | $116.57 Million | +18.44% |
| 2018-12-31 | $98.42 Million | +59.49% |
| 2017-12-31 | $61.71 Million | +28.93% |
| 2016-12-31 | $47.86 Million | +9299.04% |
| 2015-12-31 | $509.21K | +467.16% |
| 2014-12-31 | $89.78K | -61.69% |
| 2013-12-31 | $234.35K | -46.87% |
| 2012-12-31 | $441.11K | -32.91% |
| 2011-12-31 | $657.48K | -23.50% |
| 2010-12-31 | $859.39K | -80.74% |
| 2009-12-31 | $4.46 Million | -- |